The Effect of Music on Symptom Management and Quality of Life in Patients withRheumatoid Arthritis

NCT ID: NCT07087899

Last Updated: 2025-07-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

88 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-23

Study Completion Date

2024-08-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized controlled study was designed to determine the effects of music on symptom management and quality of life in patients with rheumatoid arthritis.

The study was conducted between October 2023 and August 2024 with 88 patients diagnosed with rheumatoid arthritis (41 experimental, 47 control) at the Rheumatology clinic and outpatient clinic of a university hospital in Edirne. Within the scope of this study, the Turkish validity and reliability of the Patient Symptom Thermometer scale were tested. Data were collected using the "Patient Information Form" including sociodemographic and disease-related characteristics, the "EQ-5D General Quality of Life Scale," the "Patient Symptom Thermometer," and the "DAS-28 Disease Activity Score."

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background and Aim: Rheumatoid arthritis is a chronic disease that significantly reduces quality of life due to both physical and psychosocial symptoms. Complementary methods such as music therapy are thought to be effective in alleviating symptoms and improving quality of life in patients with rheumatoid arthritis. This randomized controlled study was designed to determine the effects of music on symptom management and quality of life in patients with rheumatoid arthritis.

Material and Methods: The study was conducted between October 2023 and August 2024 with 88 patients diagnosed with rheumatoid arthritis (41 experimental, 47 control) at the Rheumatology clinic and outpatient clinic of a university hospital in Edirne. Within the scope of this study, the Turkish validity and reliability of the Patient Symptom Thermometer scale were tested. Data were collected using the "Patient Information Form" including sociodemographic and disease-related characteristics, the "EQ-5D General Quality of Life Scale," the "Patient Symptom Thermometer," and the "DAS-28 Disease Activity Score." During the first interview, the relevant scales and questionnaire were applied to patients in both the experimental and control groups. Patients in the experimental group were provided with music players and headphones to listen to music twice a day-once during the day and once at night-for one month. On the 15th and 30th days of the study, the EQ-5D General Quality of Life Scale and the Patient Symptom Thermometer were administered to the experimental group. The same scales were also applied to the control group, who did not listen to music, on the 15th and 30th days.

Financial Support: The present study was supported by the Research Fund of Trakya University. Project No: 2023/73

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatoid Arthritis Music Symptoms Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

music

The participants were informed about the research process during the first meeting. Participants were told that, if they agreed to participate in the study, they would need to listen to music twice a day-once during the day and once at night-for a period of one month. It was explained that each participant would be provided with a music player and headphones for one month, and that these items would need to be returned after the study ended. Participants were also given information on how to listen to the music. Participants were instructed on how to use the music player, informed that there were two playlists-one for daytime and one for nighttime-and advised to listen to each playlist for a maximum of 30 minutes.

Group Type EXPERIMENTAL

music

Intervention Type OTHER

listening music

control

In the first interview, participants were informed about the research process. Patient information forms and scales (EQ-5D General Quality of Life Scale, DAS-28 Disease Activity Score and Patient Symptom Thermometer) that would be used in data collection were explained to the participants. Participants were informed about how often and how these forms and scales would be applied. No intervention was applied to the participants in the control group in the study.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

music

listening music

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with RA by a physician according to the American College of Rheumatology - The European Alliance of Associations for Rheumatology (ACR-EULAR) 2010 criteria
* Patients diagnosed with Rheumatoid Arthritis at least 6 months ago
* Patients with Rheumatoid Arthritis who volunteer to participate in the study

Exclusion Criteria

* Patients with hearing problems
* Rheumatoid Arthritis patients who do not volunteer to participate in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Trakya University

OTHER

Sponsor Role collaborator

Irem Yildiz Cilengiroglu

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Irem Yildiz Cilengiroglu

Research assistant

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yıldız Çilengiroğlu

Role: PRINCIPAL_INVESTIGATOR

Trakya University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Trakya University

Edirne, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023/73

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.